#ThinkSabio Latest News AstraZeneca to buy EsoBiotec in $1 billion deal to advance cell therapy ambition Post navigation ThinkSabio-Stocks-Simplified-SEC-Update-GES (17-MAR-2025)Dyne Therapeutics, Inc. (DYN) Description, Stock price, News & Info.